Vodafone Idea adds network capacity to support rising data demand in Delhi-NCR

"Vodafone Idea has further enhanced network capacity in the circle by deploying the most efficient 900 MHz spectrum band on 2300 4G sites," the company said in a statement.

PTI

April 16, 2020 / 15:15 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Telecom operator Vodafone Idea on Thursday said it has added network capacity to cater to the rising demand for data in Delhi-NCR, amid the ongoing lockdown to contain the spread of coronavirus.

"Vodafone Idea has further enhanced network capacity in the circle by deploying the most efficient 900 MHz spectrum band on 2300 4G sites," the company said in a statement.

The sites upgraded will facilitate better indoor network experience and enhance network speed in Delhi-NCR.

"These recent network augmentation efforts are being undertaken to support the growing data demand during the national lockdown due to COVID-19 pandemic," the company said.

With this, Vodafone Idea is geared to handle the increase in demand from customers who are confined within their homes, heavily dependent on network connectivity to work, study, access essential services online, stay informed and entertained, it added.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show